Human ABCB1 confers cells resistance to cytotoxic guanidine alkaloids from Pterogyne nitens

Kazuhiro Satake1, Megumi Tsukamoto1, Yuji Mitani1

  • 1Department of Applied Biological Chemistry, Graduate School of Bioscience and Biotechnology, Chubu University, Kasugai, Japan.

Insights

Human ABCB1 (P-glycoprotein) confers multidrug resistance (MDR) by transporting guanidine alkaloids from Pterogyne nitens. This study reveals ABCB1

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) mediated by human ABCB1 (P-glycoprotein/MDR1) significantly hinders chemotherapy efficacy.
  • Understanding ABCB1's role in MDR is crucial for developing strategies to overcome treatment resistance.

Purpose of the Study:

  • To investigate the mechanism by which ABCB1 confers resistance to four guanidine alkaloids from Pterogyne nitens.
  • To assess the potential of these alkaloids as substrates for ABCB1 and their impact on ABCB1-mediated drug efflux.

Main Methods:

  • Establishment of human ABCB1-expressing cells (Flp-In-293/ABCB1) and control cells (Flp-In-293/Mock).
  • Cytotoxicity assays (MTT) to evaluate the effects of guanidine alkaloids and known ABCB1 substrates (taxol, vinblastine) on cell viability.
  • ATPase assays to determine if the guanidine alkaloids stimulate ABCB1's intrinsic ATPase activity.

Main Results:

  • ABCB1-expressing cells demonstrated resistance to the four guanidine alkaloids, galegine, nitensidine A, pterogynidine, and pterogynine, as well as to taxol and vinblastine, compared to control cells.
  • The four guanidine alkaloids exhibited cytotoxicity against both cell lines, indicating inherent activity.
  • Guanidine alkaloids were found to stimulate the ATPase activity of ABCB1, suggesting they are substrates.

Conclusions:

  • Human ABCB1 confers resistance to cytotoxic guanidine alkaloids from Pterogyne nitens.
  • ABCB1 actively transports these alkaloids, contributing to their reduced efficacy in the presence of ABCB1.
  • These findings provide insights into overcoming MDR mediated by ABCB1 for chemotherapy applications.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
7.2K
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
4.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K